IMMUNOVANT INC (IMVT:NASDAQ)
$30.47 0.21 (0.694%)
Analysed IMMUNOVANT INC (IMVT:NASDAQ) News Sources
Immunovant Shares Fall 6% After IMVT-1402 Lupus Study Misses Primary Endpoint
23-09-2026
advfn.com
Roivant’s Immunovant Stops IMVT-1402 Development in Cutaneous Lupus After Trial Miss
23-09-2026
advfn.com
Immunovant Pulls Plug On Lupus Program After Study Misses Primary Goal — IMVT Stock Heads For Over 3-Month Lows
23-09-2026
stocktwits.com
Immunovant Stock Slides After Biotech Scraps Autoimmune Drug Program
23-09-2026
yahoo.com
Roivant reports top-line data from IMVT-1402 CLE trial
24-09-2026
clinicaltrialsarena.com
Lilly’s latest China drug deal; Immunovant’s setback in lupus
24-09-2026
biopharmadive.com
Immunovant (IMVT): One Trial Failure Doesn’t Break the Bull Case
27-09-2026
yahoo.com
Immunovant (IMVT) Just Gave Investors Something To Think About
29-09-2026
yahoo.com
Why Immunovant (IMVT) Is Down 10.3% After Halting IMVT-1402 Development in Cutaneous Lupus – And What's Next
30-09-2026
yahoo.com
IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class
08-10-2026
stocktwits.com
What is the current price of IMMUNOVANT INC (IMVT:NASDAQ)?
The current price of IMMUNOVANT INC (IMVT:NASDAQ) is $30.47.
IMMUNOVANT INC (IMVT:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNOVANT INC (IMVT:NASDAQ) since the previous trading day is $0.21.
IMMUNOVANT INC (IMVT:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNOVANT INC (IMVT:NASDAQ) since the previous trading day is 0.694%.
What is the most recent average sentiment score for IMMUNOVANT INC (IMVT:NASDAQ)?
The most recent average sentiment score for IMMUNOVANT INC (IMVT:NASDAQ) is 41 out of 100.
What is the most recent average sentiment for IMMUNOVANT INC (IMVT:NASDAQ)?
The most recent sentiment for IMMUNOVANT INC (IMVT:NASDAQ) is .
SEC-8K** Filing Available For IMMUNOVANT INC (IMVT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.